Brandy Haydel
Overview
Explore the profile of Brandy Haydel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aslam S, Hussain S, Haydel B, Florman S, Gilbert A, Pereira M, et al.
Am J Transplant
. 2025 Feb;
PMID: 39956322
Transplantation from donors with HCV-viremia to recipients without HCV-viremia (HCV D+/R-) is common, but no data exist for recipients with HIV or donors with HCV/HIV co-infection. We assessed outcomes of...
2.
Parikh N, Jones P, Salgia R, Bhan I, Grinspan L, Jou J, et al.
Clin Gastroenterol Hepatol
. 2024 Aug;
23(2):281-290.e4.
PMID: 39089513
Background & Aims: Noninvasive variceal risk stratification systems have not been validated in patients with hepatocellular carcinoma (HCC), which presents logistical barriers for patients in the setting of systemic HCC...
3.
Montano-Loza A, Lytvyak E, Hirschfield G, Hansen B, Ebadi M, Berney T, et al.
J Hepatol
. 2024 May;
81(4):679-689.
PMID: 38821360
Background & Aims: Recurrent primary biliary cholangitis (rPBC) develops in approximately 30% of patients and negatively impacts graft and overall patient survival after liver transplantation (LT). There is a lack...
4.
Tran B, Moris D, Markovic D, Zaribafzadeh H, Henao R, Lai Q, et al.
Liver Transpl
. 2023 Apr;
29(7):683-697.
PMID: 37029083
HCC recurrence following liver transplantation (LT) is highly morbid and occurs despite strict patient selection criteria. Individualized prediction of post-LT HCC recurrence risk remains an important need. Clinico-radiologic and pathologic...
5.
Heldman M, Kates O, Safa K, Kotton C, Multani A, Georgia S, et al.
Clin Infect Dis
. 2022 Feb;
PMID: 35212363
Introduction: Most studies of solid organ transplant (SOT) recipients with COVID-19 focus on outcomes within one month of illness onset. Delayed mortality in SOT recipients hospitalized for COVID-19 has not...
6.
Montano-Loza A, Ronca V, Ebadi M, Hansen B, Hirschfield G, Elwir S, et al.
J Hepatol
. 2022 Feb;
77(1):84-97.
PMID: 35143897
Background & Aims: Autoimmune hepatitis can recur after liver transplantation (LT), though the impact of recurrence on patient and graft survival has not been well characterized. We evaluated a large,...
7.
Heldman M, Kates O, Safa K, Kotton C, Georgia S, Steinbrink J, et al.
Am J Transplant
. 2021 Sep;
22(1):279-288.
PMID: 34514710
Mortality among patients hospitalized for COVID-19 has declined over the course of the pandemic. Mortality trends specifically in solid organ transplant recipients (SOTR) are unknown. Using data from a multicenter...
8.
Heldman M, Kates O, Safa K, Kotton C, Georgia S, Steinbrink J, et al.
Am J Transplant
. 2021 May;
21(8):2774-2784.
PMID: 34008917
Lung transplant recipients (LTR) with coronavirus disease 2019 (COVID-19) may have higher mortality than non-lung solid organ transplant recipients (SOTR), but direct comparisons are limited. Risk factors for mortality specifically...
9.
Doyle E, Aloman C, El-Shamy A, Eng F, Rahman A, Klepper A, et al.
Sci Rep
. 2021 Jan;
11(1):1551.
PMID: 33452360
Viral hepatitis leads to immune-mediated liver injury. The rate of disease progression varies between individuals. We aimed to phenotype immune cells associated with preservation of normal liver function during hepatitis...
10.
Adeniji N, Arjunan V, Prabhakar V, Mannalithara A, Ghaziani T, Ahmed A, et al.
Liver Transpl
. 2020 Dec;
27(5):684-698.
PMID: 33306254
The incidence of hepatocellular carcinoma (HCC) is growing in the United States, especially among the elderly. Older patients are increasingly receiving transplants as a result of HCC, but the impact...